The possibility of a world without cancer just got closer. Think about this: a mouse resistant to even the most aggressive types of cancer has been created by researchers at the University of Kentucky.
"The researchers discovered that the Par-4 gene kills cancer cells, but not normal cells," Science Daily said. There are very few molecules that specifically fight against cancer cells, giving it a potentially therapeutic application."
The gene was introduced to a mouse egg which was planted in a host mother.
"The mouse itself does not express a large number of copies of this gene, but the pups do and then their pups start expressing the gene," Vivek Rangnekar, a professor of radiation medicine said. "So, we've been able to transfer this activity to generations in the mouse."
The gene kills off cancer while the mice still grow normally, having no defects, and actually living a few months longer than control mice. There have been no indications of toxic side effects.
Why This Trend Is Growing
- Cancer-resistant Animals
- Disruptive Innovation Opportunity: The creation of cancer-resistant animals using the Par-4 gene presents potential for developing novel cancer treatment strategies.
- Gene Therapy
- Disruptive Innovation Opportunity: The use of gene therapy to introduce cancer-killing genes like Par-4 holds promise for targeted and personalized cancer treatment.
- Precision Medicine
- Disruptive Innovation Opportunity: The discovery of molecules like Par-4 opens up possibilities for advancing precision medicine approaches in cancer treatment.
Industries Being Reshaped
- Biotechnology
- Disruptive Innovation Opportunity: Biotech companies can explore the use of Par-4 and similar genes in developing innovative cancer therapies and treatments.
- Pharmaceuticals
- Disruptive Innovation Opportunity: Pharmaceutical companies can leverage the Par-4 gene to create targeted drugs and therapies for cancer treatment.
- Animal Research
- Disruptive Innovation Opportunity: The field of animal research can further explore the potential of cancer-resistant animals and their impact on cancer studies and drug development.
